These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17347690)

  • 1. The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy.
    Hobikoglu GF; Norgaz T; Aksu H; Ozer O; Erturk M; Destegul E; Akyuz U; Unal Dai S; Narin A
    Can J Cardiol; 2007 Mar; 23(3):201-6. PubMed ID: 17347690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylsalicylic acid resistance and clinical outcome--the Hobikoglu study is worth noting.
    Buchanan MR
    Can J Cardiol; 2007 Mar; 23(3):207-8. PubMed ID: 17347691
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study.
    Christiaens L; Ragot S; Mergy J; Allal J; Macchi L
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):235-9. PubMed ID: 18388505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of aspirin resistance on outcome in patients with acute coronary syndrome and the effect of clopidogrel therapy in the prevention of major cardiovascular events.
    Pamukcu B; Oflaz H; Oncul A; Umman B; Mercanoglu F; Ozcan M; Meric M; Nisanci Y
    J Thromb Thrombolysis; 2006 Oct; 22(2):103-10. PubMed ID: 17008975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related effect of aspirin on laboratory-defined platelet aggregation and clinical outcome after coronary stenting.
    Kojuri J; Mahmoody Y; Zangbar Sabegh B; Jannati M; Mahboodi A; Khalili A
    Cardiovasc Ther; 2010 Jun; 28(3):147-52. PubMed ID: 20557313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes.
    Aksu H; Ozer O; Unal H; Hobikoglu G; Norgaz T; Buturak A; Soylu O; Narin A
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):686-93. PubMed ID: 19730245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid.
    Verdoia M; Schaffer A; Pergolini P; Rolla R; Barbieri L; Bellomo G; Sinigaglia F; Marino P; Suryapranata H; De Luca G;
    J Cardiovasc Pharmacol; 2015 Jul; 66(1):35-40. PubMed ID: 25714593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease.
    Sentürk T; Cordan J; Baran I; Ozdemir B; Güllülü S; Aydinlar A; Göral G
    Acta Cardiol; 2007 Apr; 62(2):135-41. PubMed ID: 17536601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance of aspirin resistance in patients with chest pain.
    Aydinalp A; Atar I; Gulmez O; Atar A; Acikel S; Bozbas H; Ozgul A; Ertan C; Ozin B; Muderrisoglu H
    Clin Cardiol; 2010 Mar; 33(3):E1-7. PubMed ID: 20155858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of aspirin resistance in patients with acute coronary syndrome.
    Hobikoglu GF; Norgaz T; Aksu H; Ozer O; Erturk M; Nurkalem Z; Narin A
    Tohoku J Exp Med; 2005 Sep; 207(1):59-64. PubMed ID: 16082156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of aspirin resistance on the long-term cardiovascular mortality in patients with non-ST segment elevation acute coronary syndromes.
    Foussas SG; Zairis MN; Tsirimpis VG; Makrygiannis SS; Patsourakos NG; Adamopoulou EN; Mytas DZ; Prekates AA; Perdiou AJ; Tsoukanas VK; Argyrakis SK
    Clin Cardiol; 2009 Mar; 32(3):142-7. PubMed ID: 19301289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes.
    Lenderink T; Heeschen C; Fichtlscherer S; Dimmeler S; Hamm CW; Zeiher AM; Simoons ML; Boersma E;
    J Am Coll Cardiol; 2006 Jan; 47(2):307-11. PubMed ID: 16412852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nardin M; Verdoia M; Pergolini P; Rolla R; Barbieri L; Schaffer A; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):567-574. PubMed ID: 27134063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.